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A B S T R A C T
In humans, Mycoplasma pneumoniae and Bordetella pertussis infections are suggested to trigger or
exacerbate asthma. Whether Mycoplasma or Bordetella are associated with chronic inﬂammatory
bronchial diseases in dogs has not been investigated. The aim of this study was to assess detection rates of
Mycoplasma canis (M. canis), M. cynos and Bordetella bronchiseptica (Bb), in dogs with eosinophilic
bronchopneumopathy (EBP) and chronic bronchitis (CB), compared with healthy dogs. Speciﬁc
quantitative PCR (qPCR) analysis for M. canis, M. cynos and Bb were retrospectively performed on
bronchoalveolar lavage ﬂuid (BALF) collected from 24 dogs with EBP, 21 dogs with CB and 15 healthy
dogs. Possible associations between qPCR results and age, BALF cytology or clinical severity scores (CSS)
in dogs with EBP were investigated.
There was no difference in M. canis, M. cynos and Bb detection rates in dogs with EBP (n = 6, n = 2 and
n = 6, respectively) and dogs with CB (n = 2, n = 2 and n = 2, respectively) compared with control dogs
(n = 4, n = 2 and n = 2, respectively). In dogs with EBP, the proportion that were qPCR-positive for Bb was
higher in dogs with higher CSS (P = 0.014) and BALF from Bb-positive dogs had higher percentage of
neutrophils (P < 0.001). Among dogs that were qPCR-positive for Bb, moderate to high loads were only
detected in dogs with EBP. M. canis and M. cynos detection was not associated with EBP or CB; higher Bb
loads were only present in dogs with EBP and high CSS. A possible cause and effect relationship between
Bb infection or load and EBP remains unclear and requires further investigation.
© 2017 Elsevier Ltd. All rights reserved.
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Idiopathic eosinophilic bronchopneumopathy (EBP) is a chronic
disease characterized by eosinophilic inﬁltration of the lung and
bronchial mucosa in young adult dogs (Corcoran et al., 1991; Clercx
et al., 2000; Rajamäki et al., 2002). Dogs with non-speciﬁc chronic
bronchitis (CB) also present with chronic cough, but are usually
older. The etiology of both inﬂammatory conditions remains
unclear. In EBP, an underlying immunologic hypersensitivity is* Corresponding author.
E-mail address: morgane.canonne-guibert@vet-alfort.fr (A.M. Canonne).
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1090-0233/© 2017 Elsevier Ltd. All rights reserved.suspected, but the inciting antigens remain mostly unidentiﬁed
(Clercx et al., 2002; Peeters et al., 2005; Clercx and Peeters, 2007).
For both of these bronchial diseases, current treatments consist of
long-term oral and/or inhaled glucocorticoids (Clercx et al., 2000;
Bexﬁels et al., 2006; Rozanski, 2014; Canonne et al., 2016b).
In humans, infections with Mycoplasma pneumoniae (M.
pneumoniae) have been associated with asthma for decades
(Hansbro et al., 2004; Atkinson, 2013; Ye et al., 2014). M.
pneumoniae infection is associated with acute exacerbation of
adult asthmatics and future development of asthma in children
(Hansbro et al., 2004) and speciﬁc treatment improves pulmonary
function in asthmatics (Kraft et al., 2002). However, Bordetella
pertussis (B. pertussis) has been also discussed as potential trigger
in human inﬂammatory bronchial disease and asthma (Harju et al.,
2006; Wakashin et al., 2008; Nicolai et al., 2013; Yin et al., 2017).
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infection was documented to exacerbate airway signs (Ennis et al.,
2004; Kavanagh et al., 2010).
Although Mycoplasma cynos (M. cynos) has been identiﬁed as an
emerging, possibly contagious, and lethal pathogen in dogs with
canine infectious respiratory disease (CIRD, kennel cough or canine
infectious tracheobronchitis; Rycroft et al., 2007; Zeugswetter
et al., 2007; Mannering et al., 2009; Priestnall et al., 2014), but the
exact role of M. canis and M. cynos as primary respiratory
pathogens still remains unclear (Chandler and Lappin, 2002;
Chalker et al., 2004; Chan et al., 2013). Moreover, a recent study
demonstrated the impact of oral bacterial contamination on
Mycoplasma-speciﬁc PCR results of bronchoalveolar lavage ﬂuid
(BALF; Chan et al., 2013), making the investigation of a potential
primary role of Mycoplasma spp. in canine lower respiratory
conditions even more complex.
Bordetella bronchiseptica (Bb) is recognized as one of the
primary causative pathogen agents of CIRD. Bb can exist in
respiratory tract of dogs as either commensal or pathogen (Bemis
et al.,1977; Bemis,1992; Schulz et al., 2014). Currently, quantitative
PCR (qPCR) assays provide highly sensitive and speciﬁc detection
of of Bb, M. canis and M. cynos (Chan et al., 2013; Schulz et al., 2014;
Lavan and Knesl, 2015; Canonne et al., 2016a). However, the
potential role of these infectious agents in chronic inﬂammatory
bronchial diseases in dogs have not yet been investigated and
whether these bacterial agents could act as triggers or exacerbat-
ing agents in dogs with EBP is unknown.
The aim of the present study was to evaluate the presence and
bacterial load of M. canis, M. cynos and Bb in steroid-naïve dogs
newly-diagnosed with EBP and compare the results to those for
dogs with non-speciﬁc CB and healthy dogs, using speciﬁc qPCR
analysis performed on BALF samples. Additionally, potential
associations between positive qPCR results for any of these
bacterial species and the clinical severity of EBP were assessed.
Materials and methods
Dogs
Client-owned dogs presented to the National Veterinary School of Alfort
Companion Animal Hospital between March 2009 and February 2016 and
diagnosed with EBP or CB were prospectively recruited.
Deﬁnitive diagnosis of idiopathic EBP and CB was made in accordance with
criteria previously described (Clercx et al., 2000; Rozanski, 2014). Brieﬂy, this was
based on compatible respiratory clinical complaints, radiological changes,
bronchoscopic ﬁndings, analysis of the BALF including culture and standard
cytological examination and, in some cases, histopathological examination of
endoscopic bronchial mucosal biopsies. In dogs with CB, bacterial involvement in
neutrophilic airway inﬂammation was excluded based on cytology (lack of
degenerative neutrophils, absence of intra-cellular bacteria), culture and positive
response to steroids. In dogs with EBP, exclusion of other causes of eosinophilic
airway inﬂammation, including cardiopulmonary parasites, was required to
deﬁnitively diagnose idiopathic EBP by using fecal and BALF analysis (Baermann
method, cytology and qPCR on BALF). All dogs were newly-diagnosed and steroid-
naïve.
In dogs with a ﬁnal diagnosis of idiopathic EBP, a clinical severity score (CSS; 1-
5/5) was assessed at the time of diagnosis based on severity and frequency of cough,
evidence of exercise intolerance or lethargy, as previously deﬁned (Canonne et al.,
2016b). Cough was scored from 1-3/3 depending on frequency and severity;
presence of retching or exercise intolerance was recorded with 1 additional point.
Points obtained from cough scoring, retching and exercise intolerance were added
to a maximum total of 5 points.
Bronchoscopy, BALF procedure and processing were performed as described
earlier (Clercx et al., 2000). Brieﬂy, dogs were anesthetized using various anesthetic
protocols after a 5 min pre-oxygenation period. Five to 20 mL aliquots (depending
on bodyweight) of sterile saline (NaCl 0.9%) were instilled twice into a same
bronchus and a third time into a different lung lobe via a ﬂexible pediatric
endoscope (Fujinon, Pediatric video-bronchoscope EB-530S), followed by immedi-
ate aspiration by gentle automated suction. The recovered BALF was immediately
processed. Aliquots of naïve BALF were used for semi-quantitative bacterial culture
(Collard Laboratories, according to methods previously described; Peeters et al.,
2000), total cell count determination using a hemocytometer, and cytospinpreparation (centrifugation at 1400 rpm, 197 g, for 4 min at 20 C, Thermo Shandon
Cytospin 4). Differential cell count calculations were established by counting a total
of 300 cells viewed on high power ﬁelds on the cytospin preparation; 400–600/mL
was considered a normal cell count. BALF cytology was considered normal if there
were <12% neutrophils and <7% eosinophils. The remaining recovered BALF was
centrifuged at 1300 g for 15 min at 4 C. The resulting supernatant and cell pellet
were stored separately at 80 C. Additionally, angiostrongylosis was excluded in all
dogs with EBP based on a negative quantitative PCR (qPCR) test results in BALF
(Canonne et al., 2016b). Additionally, all dogs were treated at the time of diagnosis
with anthelmintics (fenbendazole 50 mg/kg q24 h for 5 days, Panacur Intervet
International via MSD Animal Health, or milbemycin oxime 1 mg/kg once,
Milbemax Novartis), while results were pending.
Control group
Stored BALF samples collected from 15 healthy dogs were available from
previous studies for which ethical approval had been previously obtained from the
University Local Ethical Committee (University Local Ethical Committee Approval
number 1435; Approval date 30th April 2013). The stored samples were collected
from healthy dogs belonging to veterinary staff or students (n = 13) or from shelters
(n = 2), and none had either history or clinical signs of respiratory disease.
Bronchoscopy, BALF and laboratory processing and storage had been performed as
for dogs with EBP and CB and both total cell counts and cytological examination of
cytocentrifuged preparations of BALF were within normal limits in each dog.
Quantitative PCR analysis
Quantitative PCR analysis was performed on stored BALF for M. canis, M. cynos
and Bb in dogs with EBP, CB and healthy dogs. The frozen pelleted cells were thawed
and, after re-suspension in a small volume of sterile saline (0.9% NaCl), samples
were sent to the laboratory for qPCR analysis. The qPCR results were expressed as Ct
values. Ct values were arbitrarily further categorized into ﬁve groups: very high load
(Ct < 20), high load (20.1–24), moderate load (24.1–28), low load (Ct 28.1–32) and
very low load (>32.1).
Statistical analysis
Statistical analyses were performed with a commercially available software
(XLstat software). Data were expressed for continuous and categorical variables as
median with range or as proportions, respectively.
Chi-square or Fisher’s exact (when necessary) tests were used to compare the
proportions of qPCR detection of M. canis, M. cynos and Bb between dogs with EBP
and healthy dogs and between dogs with EBP and dogs with CB. Dogs with EBP were
grouped according to CSS into two groups: dogs with CSS  3 (mild clinical
severity) and dogs with CSS > 3 (moderate-to-severe clinical signs). The proportion
of dogs with EBP and positive qPCR results for M. canis, M. cynos and Bb were
compared between dogs with CSS  3 and dogs with CSS > 3 by using exact Fisher’s
exact test (for n  5). For each bacterial agent, the median age of dogs with EBP with
positive qPCR was compared to the median age of dogs with EBP with negative qPCR
using Wilcoxon–Mann Whitney tests. For each bacterial agent, median total cell
count and percentage of neutrophils in the BALF of dogs with EBP that were qPCR-
positive were compared to BALF parameters from dogs with EBP that were qPCR-
negative by using Wilcoxon–Mann Whitney’s test.
Values of P  0.05 were considered statistically signiﬁcant.
Results
A convenience sample of 24 dogs with EBP (median age, 4.2y
[0.9–13.2]) and 21 dogs with non-speciﬁc CB (median age, 8.0 [0.9–
14.0]) were selected.
Table 1 reports the proportions of dogs with positive qPCR
result for M. canis, M. cynos and Bb in each of the three groups. For
each bacterial agent, no signiﬁcant difference in qPCR detection
rates were found between dogs diagnosed with EBP and healthy
dogs and between dogs with EBP and dogs with CB (Table 1).
Among dogs with positive qPCR for M. cynos on BALF, Ct values
corresponding to very high load were only found in dogs with
inﬂammatory bronchial disease. Among dogs with positive qPCR
for Bb on BALF, moderate or high load were only found in dogs with
EBP.
In dogs with EBP, CSS varied between two and ﬁve at the time of
diagnosis; total BALF cell counts were 700–6000/mL; % eosinophils
was 20–85; and % neutrophils was 1–30 (Table 2). The proportion
of dogs with Bb in the BALF was signiﬁcantly higher in dogs with
CSS > 3 (5/9, 56%) than in dogs with CSS  3 (1/15, 7%; P = 0.015).
Table 1
Frequency of positive qPCR performed on bronchoalveolar lavage ﬂuid for Mycoplasma canis,Mycoplasma cynos and Bordetella bronchiseptica in dogs with eosinophilic
bronchopneumopathy (EBP), chronic bronchitis (CB) and healthy dogs.
Dogs with EBP Dogs with CB Healthy dogs P
Mycoplasma canis 6/24 (25%)a,b 2/21 (10%)b 4/15 (13%)a 1.00a
0.25b
Very high load (Ct < 20) – –
High load (20.1–24) – –
Moderate load (24.1–28) 1 –
Low load (Ct 28.1–32) 3 – 1
Very low load (>32.1) 2 2 3
Mycoplasma cynos 2/24 (8%)a,b 2/21 (10%)b 2/15 (13%)a 0.63a
1.00b
Very high load (Ct < 20) 2 1 –
High load (20.1–24) – – –
Moderate load (24.1–28) – – 1
Low load (Ct 28.1–32) – – –
Very low load (>32.1) – 1 1
Bordetella bronchiseptica 6/24 (25%)a,b 2/21 (10%)b 2/15 (13%)a 0.45a
0.25b
Very high load (Ct < 20) – – –
High load (20.1–24) 1 – –
Moderate load (24.1–28) 2 – –
Low load (Ct 28.1–32) – – –
Very low load (>32.1) 3 2 2
a,bGroups with same letter were compared.
54 A.M. Canonne et al. / The Veterinary Journal 232 (2018) 52–56For the mycoplasmal species, there was no difference in CSS
between dogs with qPCR-positive qPCR-negative results (data not
shown). In dogs with EBP, the median age of those that were qPCR-
negative for Bb was not different from that for qPCR-positive dogs
(3.7 years [0.9–13.0] and 5.8 years [0.9–13.2], respectively; P = 0.44)
and median age for qPCR-negative and qPCR-positive for M. canis
and M. cynos was not different (M. canis, 4.3 years [0.9–13.0] and
2.9 years [1.6–13.2], respectively; P = 0.73; M. cynos, 4.1 years
[0.9–13.0] and 7.6 years [0.9–13.2], respectively; P = 0.71).
In dogs with EBP, for each bacterial agent taken separately,
median BALF total cell counts from qPCR-negative dogs was not
different from that from qPCR-positive dogs (data not shown).
Median % neutrophils in BALF from dogs qPCR-positive for Bb and
M. cynos were signiﬁcantly higher than median values from dogs
that were qPCR-negative (Bb, 15% [3–20] and 3.5% [1–30],
respectively; P < 0.001; M. cynos, 12.5% (10–15) and 3.5% [1–30],
respectively; P = 0.02). Median % neutrophils in BALF from dogs
with positive and negative qPCR results for M. canis were not
different (data not shown).
Discussion
The objectives of the present study were to detect the presence
and load of M. canis, M. cynos and Bb in dogs with EBP compared
with dogs diagnosed with non-speciﬁc CB and healthy controls,
using speciﬁc qPCR on BALF samples. The results of the present
study suggest that any association between either mycoplasmal
species and canine EBP is unlikely. However, in dogs with EBP, the
probability of a positive qPCR result for Bb increased statistically
with clinical severity. Moreover, among dogs with positive qPCR
results for M. cynos or Bb, Ct values indicating moderate, high or
very high load were found only in dogs with inﬂammatory
bronchial disease. The small group size of dogs that were qPCR-
positive precluded statistical comparisons of bacterial load
between groups.
Human asthma and canine EBP have different characteristics;
for example, bronchial hyper-responsiveness is not a hallmark of
canine EBP. However, human asthma and canine EBP are both TH2-
driven inﬂammatory conditions characterized by eosinophilic
inﬁltration. The role of bacterial genera known to be implicated in
the induction or exacerbation of human asthma have not been
investigated in dogs with EBP. In humans, infection withM. pneumoniae can favour the development of asthma in
predisposed patients and speciﬁc treatment with clarithromycin
improves pulmonary function (Martin et al., 2001; Kraft et al.,
2002; Hansbro et al., 2004; El Sayed Zaki et al., 2009; Atkinson,
2013; Ye et al., 2014). The proportion of asthmatics who have both
IgM and IgG for M. pneumoniae increases with clinical severity
(Iramain et al., 2016; Yin et al., 2017). In a mouse model, single
exposure to a speciﬁc toxin of M. pneumoniae was shown to be
sufﬁcient to cause asthma-like disease with histological evidence
of pulmonary eosinophilic inﬂammation (Medina et al., 2012). Our
study failed to support the hypothesis of a similar association
between mycoplasmal infection or carriage and EBP in dogs. This
could possibly be explained by the relatively small sample size
limiting the power of statistical tests for comparison. In human
asthma, the role of Mycoplasma spp. has sometimes been
investigated using PCR, but is mainly assessed using serum
Mycoplasma-speciﬁc antibodies (El Sayed Zaki et al., 2009; Iramain
et al., 2016); such antibodies were not evaluated in our study.
Additionally, the potential therapeutic beneﬁt of a speciﬁc
antibiotic treatment, such as doxycycline, macrolide or ﬂuoro-
quinolone, has not been evaluated in dogs with EBP or CB and
positive qPCR results for M. cynos. Lastly, involvement of other
mycoplasmal species in canine chronic lower airway inﬂammation
could not be excluded; several other Mycoplasma species have
been investigated in dogs (Chalker et al., 2004), but until recently,
accurate diagnostic methods such as qPCR were not available for
less common canine mycoplasmal species.
Although Bb was not more frequently detected in dogs with EBP
than in dogs with CB or healthy dogs, the frequency of Bb-positive
dogs with EBP was positively associated with clinical severity.
Among dogs with positive qPCR for Bb on BALF, moderate or high
loads were found in dogs with EBP only. Whether Bb is able to
trigger eosinophilic lower airway inﬂammation and whether the
inﬂammatory context in airways favours Bb growth in dogs is
unknown. In humans, Bb infections are unusual and almost
exclusively described in immunocompromized patients with
contact with animals. B. pertussis is more common and has been
discussed as a triggering and exacerbating factor in chronic
inﬂammatory bronchial diseases; B. pertussis toxin favours
eosinophilic airway inﬂammation (Ennis et al., 2004; Harju
et al., 2006; Wakashin et al., 2008; Kavanagh et al., 2010; Nicolai
et al., 2013; Yin et al., 2017). Despite a large overlap between values,
Table 2
Signalment, qPCR results from bronchoalveolar lavage ﬂuid (BALF) for Mycoplasma canis, M. cynos, Bordetella bronchiseptica (Bb), clinical severity scores (CSS) and BALF
cytology in dogs with eosinophilic bronchopneumopathy (EBP).
Case Breed Sex Age
(years)




1 Mixed-breed M 13 – – – 2 1400/mL,
20%–5%
Negative
2 Mixed-breed F 6 – – – 2 4000/mL,
85%–3%
Negative
3 Shar pei F 3 – – – 2 2500/mL,
65%–5%
Negative
4 Shi tzu M 4 – – – 3 3000/mL,
60%–1%
Negative
5 Shi tzu M 1.2 – – – 3 1600/mL,
55%–30%
Negative
6 Mixed-breed M 12.4 – VH – 3 1900/mL,
30%–10%
Negative
7 Beauceron F 1.6 L – – 3 1800/mL,
55%–3%
Negative
8 Shar pei F 13.2 M – M 3 2000/mL,
55%–3%
Negative
9 Mixed-breed F 3.4 – – – 3 1400/mL,
60%–1%
Negative
10 Tervuren M 2.0 VL – – 3 700/mL,
55%–16%
Negative
11 Whippet F 3.0 L – – 3 1100/mL,
20%–3%
Negative
12 Golden retriever F 3.3 – – – 3 1300/mL,
80%–4%
Negative
13 Brittany spaniel F 7.1 VL – – 3 800/mL,
25%–3%
Negative
14 Siberian husky M 0.9 – – – 3 1500/mL,
80%–3%
Negative
15 Mixed-breed F 5.2 – – – 3 4000/mL,
85%–7%
Negative
16 Doberman M 0.9 – – VL 4 2000/mL,
40%–10%
Negative
17 Siberian husky F 1.0 – – – 4 1600/mL,
75%–15%
Negative
18 Basset artesien M 4.3 – – – 4 2500/mL,
35%–3%
Negative
19 Whippet F 8 – – – 4 1700/mL,
40%–15%
Negative
20 Brittany spaniel F 5.7 – – M 5 2500/mL,
70%–20%
Negative
21 Border terrier M 2.9 L VH H 5 6000/mL,
20%–15%
Negative
22 Fox terrier F 10.0 – – VL 5 1800/mL,
58%–20%
Negative
23 Jack Russell terrier M 4.4 – – – 5 3100/mL,
62%–1%
Negative
24 Tervueren M 6 – – VL 5 4500/mL,
60%–15%
Negative
M, male; F, female; VH, very high load; H, high load; M, moderate load; L, low load; VL, very low load (see details in text and Table 1).
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with positive qPCR for Bb than in dogs with EBP with negative qPCR
results, while median total cell counts were not different.
Consequently, larger studies investigating the role of Bb in dogs
with EBP and potential clinical beneﬁts of treatment for Bb-
positive dogs are needed.
The potential inﬂuence of any previous Bb vaccination on
positive samples could not be completely ruled out in our study.
However, among dogs with known vaccination status, the number
of vaccinated dogs was not different among the three groups (data
not shown). In puppies vaccinated with a single dose of modiﬁed
live intranasal vaccine, Bb was detected by qualitative PCR during
1 month after vaccination (Ruch-Gallie et al., 2016). To our
knowledge, the impact of previous vaccination on qPCR performed
on BALF has not been investigated. Nevertheless, none of the dogs
in our study were vaccinated within 2 months prior to diagnosis.Because of this, we assumed that the impact of previous
vaccination on qPCR for Bb in BALF was minimal.
As all dogs with EBP and CB were referred cases, the impact of
previous antimicrobial treatment, such as doxycycline or ﬂuo-
roquinolones, on our qPCR results cannot be completely ruled out;
this might have caused underestimates of the presence of each
agent in diseased dogs compared to healthy dogs. This potential
risk was considered quite low since there was usually a wash-out
period of at least 2 days before BAL procedures.
The last minor limitation of this study was the lack of validation
of CSS that was used to score clinical signs in dogs with EBP. To limit
variability, CSS was attributed to each dog with EBP by only one
author (AMC), who remained masked to qPCR results. Intra- and
inter-observer variabilities in CSS evaluation should be assessed
before this scoring system can be used on a larger scale in dogs
with EBP.
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The present investigation by qPCR on BALF does not support any
role for M. canis and M. cynos in the pathogenesis of EBP in dogs.
Nevertheless, in dogs with EBP, Bb was detected more frequently in
those with more severe clinical signs. Moreover, among dogs that
were qPCR-positive for Bb, moderate or high loads were observed
in only dogs with EBP. Despite both observations, a cause and effect
relationship between the presence and load of Bb and severe
canine EBP remains unclear. However, since dogs with EBP could
potentially act as Bb carriers and a source of infection for
susceptible dogs, screening for this pathogen should be performed
in dogs newly-diagnosed with EBP, particularly in cases where the
clinical presentation is severe, there is a high percentage of
neutrophils in the BALF, or if there has been an acute exacerbation
of clinical signs in previously diagnosed cases. These Bb-positive
dogs should be appropriately accordingly and respiratory signs
should be monitored closely.
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